Fundz

CellVoyant Raises £7.6M in Seed Funding

PRIVATEFeb 26, 2024

Amount Raised

£7.6 Million

Round Type

Seed

BristolBiotechnology

Investors

Air Street CapitalVerve VenturesHorizons VenturesOctopus Ventures

Description

CellVoyant, a Bristol, UK-based AI-first biotechnology spin-out from the University of Bristol, raised £7.6M in Seed funding. The round was led by Octopus Ventures, with participation from Horizons Ventures, Verve Ventures, and Air Street Capital. The company intends to use the funds to scale the business, including doubling the team size over the next two years, expanding laboratory and experimental infrastructure, and advancing AI capabilities.

Quick answer

CellVoyant raised £7.6 Million in a Seed round, dated February 26, 2024. Investors: Air Street Capital, Verve Ventures, Horizons Ventures and Octopus Ventures. CellVoyant is based in Bristol, Pennsylvania, United States.

How much did CellVoyant raise?
CellVoyant raised £7.6 Million in a Seed round on February 26, 2024.
Who invested in CellVoyant?
Air Street Capital, Verve Ventures, Horizons Ventures and Octopus Ventures are named as investors in this round.
What does CellVoyant do?
CellVoyant is a University of Bristol spinout biotech startup that utilizes AI imaging technology to aid in the more efficient manufacture of stem cell therapies for various medical conditions.
Where is CellVoyant based and how big is it?
CellVoyant is based in Bristol, Pennsylvania, United States.
Who are the decision-makers at CellVoyant?
Fundz holds 1 contact at CellVoyant. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CellVoyant that raised within 45 days of this round, from Fundz verified event records.

  • RenovoRx raised $11M on April 11, 2024.
  • Qlaris Bio raised $24M on April 11, 2024.
  • Enatom raised $967K (Seed) on April 11, 2024.
  • DeepCure raised $25M (Series A) on April 11, 2024.
  • FundaMental Pharma raised $14M (Seed) on April 11, 2024.
  • Insight Molecular Diagnostics Inc. raised $16M on April 11, 2024.

Who to call at CellVoyant, and when

A new round usually means CellVoyant is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CellVoyant raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CellVoyant, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CellVoyant. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CellVoyant

Location

Bristol, Pennsylvania, United States

About

CellVoyant is a University of Bristol spinout biotech startup that utilizes AI imaging technology to aid in the more efficient manufacture of stem cell therapies for various medical conditions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CellVoyant raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for CellVoyant's next move

See what Strategic adds

CellVoyant raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.